ClinVar Miner

Submissions for variant NM_006949.4(STXBP2):c.568C>T (p.Arg190Cys)

gnomAD frequency: 0.00041  dbSNP: rs370053399
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000477888 SCV000769113 likely benign Familial hemophagocytic lymphohistiocytosis 5 2024-01-31 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000658815 SCV000780611 uncertain significance not provided 2017-12-01 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000658815 SCV000861500 uncertain significance not provided 2018-06-11 criteria provided, single submitter clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000477888 SCV000899004 uncertain significance Familial hemophagocytic lymphohistiocytosis 5 2021-03-30 criteria provided, single submitter clinical testing STXBP2 NM_006949 exon 7 p.Arg190Cys (c.568C>T): This variant has been reported in the literature in 1 individual with hemophagocytic lymphohistiocytosis as a double heterozygote (Zhang 2014 PMID:24916509). This variant is present in 0.2% (21/8488) of Ashkenazi Jewish alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs370053399). This variant is present in ClinVar (Variation ID:404841). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Illumina Laboratory Services, Illumina RCV000477888 SCV001288653 uncertain significance Familial hemophagocytic lymphohistiocytosis 5 2017-05-26 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004526685 SCV005039758 uncertain significance not specified 2024-03-19 criteria provided, single submitter clinical testing Variant summary: STXBP2 c.568C>T (p.Arg190Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00048 in 157426 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in STXBP2 causing Familial Hemophagocytic Lymphohistiocytosis (0.00048 vs 0.0022), allowing no conclusion about variant significance. c.568C>T has been reported in the literature in heterozygous individuals affected with Familial Hemophagocytic Lymphohistiocytosis (e.g. Zhang_2014, Benavides_2020, Vinas-Gimenez_2021), and some were reported to also have variants in other genes. These reports do not provide unequivocal conclusions about association of the variant with Familial Hemophagocytic Lymphohistiocytosis. Publications report experimental evidence evaluating an impact on protein function, finding that the variant results in diminished degranulation and target cell apoptosis (Benavides_2020, Vinas-Gimenez_2021). However, this does not allow convincing conclusions about the variant effect. The following publications have been ascertained in the context of this evaluation (PMID: 24916509, 33162974, 34630398, 31286990, 37477760). ClinVar contains an entry for this variant (Variation ID: 417965). Based on the evidence outlined above, the variant was classified as uncertain significance.
Division of Human Genetics, Children's Hospital of Philadelphia RCV000477888 SCV000536933 uncertain significance Familial hemophagocytic lymphohistiocytosis 5 2016-05-28 no assertion criteria provided research
GeneReviews RCV000477888 SCV001976574 not provided Familial hemophagocytic lymphohistiocytosis 5 no assertion provided literature only Dominant-negative variant assoc w/fHLH in 1 infant [Benavides et al 2020]

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.